HeartRhythm

DECEMBER 20, 2023

As it provides stable R-wave sensing, LBBP has been recently utilized to provide sensing of ventricular arrhythmia in patients receiving implantable cardioverter defibrillator(ICD) with CRT

Defibrillator 40

Defibrillator Arrhythmia 40

HeartRhythm

MARCH 31, 2025

Implantable cardioverter-defibrillators (ICDs) are essential in managing life-threatening arrhythmias, but adverse events (AEs) related to these devices can compromise patient safety and clinical outcomes.

Defibrillator 40

Defibrillator Arrhythmia Outcomes 40

HeartRhythm

MARCH 31, 2025

There is limited data on healthcare utilization and length of stays for underrepresented racial and ethnic groups patients who receive implantable cardioverter defibrillators (ICDs) for ventricular arrhythmias.

Defibrillator 40

Defibrillator Arrhythmia Hospital 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 27, 2023

However, ventricular arrhythmias (VA) are common, are mostly secondary to underlying myocardial scar, and have a higher incidence in patients with pre-LVAD VA.

Defibrillator 40

Defibrillator Arrhythmia Best Practices Quality of Life 40

HeartRhythm

MARCH 31, 2025

Ventricular arrhythmias are common in adult and pediatric patients (pts) with end-stage heart failure requiring ventricular assist devices (VADs). Studies assessing the utility of implantable cardiac defibrillator (ICD) placement in adult patients with VADs show conflicting data regarding its mortality benefit.

Defibrillator 40

Defibrillator Pediatrics Transplant Heart Failure 40

HeartRhythm

MARCH 31, 2025

Low QRS amplitude of subcutaneous implantable cardioverter-defibrillator (S-ICD) could cause undersensing of fatal ventricular arrhythmias, inappropriate shocks due to oversensing of myopotential or noise by auto gain control, and deactivation of SMART Pass. Little is known about the cause of low QRS amplitude of S-ICD.

Defibrillator 40

Defibrillator Arrhythmia 40

HeartRhythm

APRIL 30, 2024

The Extravascular Implantable Cardioverter Defibrillator (EV ICD) has demonstrated to be efficacious in the treatment of ventricular arrhythmias. Predicators of lead rotation have yet to be elucidated. The management of patients affected by lead rotation is of clinical significance and not yet described.

Defibrillator 40

Defibrillator Arrhythmia 40

HeartRhythm

MARCH 31, 2025

An Implantable cardiac defibrillator (ICD) is recommended for primary and secondary prevention of cardiac arrest from fast ventricular arrhythmias. Patients with an ICD often have limited knowledge about end-of-life (EOL) ICD management options, and many approach the final stages of life with active shock therapy.

Defibrillator 40

Defibrillator Cardiac Arrest Nursing Arrhythmia 40

HeartRhythm

SEPTEMBER 16, 2024

Implantable cardioverter-defibrillators (ICDs) are established as the standard of care for patients who are deemed at increased risk of life-threatening ventricular arrhythmias. Device-specific fears and symptoms of anxiety are the most common psychological sequelae experienced by ICD patients.1

Defibrillator 40

Defibrillator Quality of Life Arrhythmia 40

HeartRhythm

MAY 23, 2024

Despite the implantable cardioverter defibrillator’s (ICD) effectiveness in saving patients with life-threatening ventricular arrhythmias (VAs), the temporal occurrence of VA following ICD implantation is unpredictable.

Arrhythmia 40

Arrhythmia Defibrillator 40

HeartRhythm

APRIL 30, 2024

Ventricular arrhythmias and heart failure are common presentations of cardiac sarcoidosis (CS). Guidelines support implantable cardioverter-defibrillator (ICD) for many CS patients with reduced ejection fraction, but arrhythmic outcomes are poorly understood.

Defibrillator 40

Defibrillator Heart Failure Arrhythmia Outcomes 40

HeartRhythm

AUGUST 31, 2024

Implantable cardioverter defibrillators (ICD) are effective at terminating ventricular arrhythmias (VA), though have significant drawbacks. The opportunity to predict the onset of arrhythmia holds promise for insight into VA initiation and the opportunity to deliver therapy prior to an event.

Arrhythmia 40

Arrhythmia Defibrillator 40

HeartRhythm

JULY 14, 2024

The feasibility and safety of utilizing LBBAP lead to provide sensing of ventricular arrhythmia in patients receiving implantable cardioverter defibrillator(ICD) with CRT has been demonstrated recently

Defibrillator 40

Defibrillator Arrhythmia 40

HeartRhythm

OCTOBER 24, 2024

Less is known about the relationship between NAFLD, ventricular arrhythmias (VAs), and cardiovascular events. Patients with nonalcoholic fatty liver disease (NAFLD) are at risk for cardiovascular diseases.

Arrhythmia 40

Arrhythmia Defibrillator Cardiovascular Disease 40

HeartRhythm

MARCH 31, 2025

Implantable cardioverter-defibrillator (ICD) therapy improves outcomes, though recurrent VT, ICD discharges, and cardiac hospitalizations remain a source of significant morbidity and are associated with increased mortality. Anti-arrhythmic medications are generally effective, but long-term use is associated with significant side effects.

Tachycardia 40

Tachycardia Arrhythmia Ablation Defibrillator 40

Medical Xpress - Cardiology

APRIL 10, 2024

The late-breaking science was presented at EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).

Hospital 74

Hospital Ablation Tachycardia Defibrillator 74

HeartRhythm

DECEMBER 31, 2023

This 1997 figure is the first conclusive evidence that the implantable cardioverter-defibrillator (ICD) reduces overall mortality compared with drugs in patients with life-threatening ventricular arrhythmias (from The New England Journal of Medicine, reprinted with permission from Massachusetts Medical Society).1

Defibrillator 40

Defibrillator Arrhythmia 40

Dr. Smith's ECG Blog

JULY 25, 2024

He was defibrillated into VT. He then underwent dual sequential defibrillation into asystole. See these related cases: Cardiac arrest, defibrillated, diffuse ST depression and ST Elevation in aVR. This patient was witnessed by bystanders to collapse. They started CPR. EMS arrived and found him in Ventricular Fibrillation (VF).

Cardiac Arrest 123

Cardiac Arrest Ischemia Tachycardia Defibrillator 123

HeartRhythm

FEBRUARY 22, 2024

Arg14del) variant carriers are at risk of developing malignant ventricular arrhythmias (MVA). Accurate risk stratification allows for timely implantation of intracardiac defibrillators (ICD) and is currently performed using a multimodality prediction model. Phospholamban (PLN) p.(Arg14del)

Arrhythmia 40

Arrhythmia Defibrillator Cardiomyopathy 40

HeartRhythm

APRIL 30, 2024

Consequent implantable cardioverter-defibrillator (ICD) shocks can tremendously affect quality of life. Stereotactic arrhythmia radioablation (STAR) seems to reduce the number of ICD/external shocks, although most studies on STAR published to date only report results up to 12 months.

Arrhythmia 40

Arrhythmia Quality of Life Defibrillator Tachycardia 40

Journal of Cardiovascular Electrophysiology

JANUARY 29, 2024

Abstract The subcutaneous implantable cardioverter defibrillator (S-ICD) was developed as an alternative to the traditional transvenous implantable cardioverter defibrillator (TV-ICD), aiming to provide easier implantation, simplified detection algorithm of malignant ventricular arrhythmias and prevention from placing components in the cardiovascular (..)

Defibrillator 40

Defibrillator Electrocardiogram Technology Arrhythmia 40

DAIC

MARCH 26, 2024

The most common arrhythmia, atrial fibrillation , will affect approximately 12.1 Pacemakers and implantable cardioverter defibrillators (ICDs) are the standard of care to regulate a patient’s irregular heartbeat. million people in the United States by 2030, based on an estimation from the Centers for Disease Control and Prevention.

Pacemaker 105

Pacemaker Heart Rhythm Arrhythmia Atrial Fibrillation 105

HeartRhythm

MARCH 31, 2025

MODULAR ATP, a multicenter, international trial, assesses a subcutaneous ICD (S-ICD) in wireless communication to a novel leadless pacemaker (LP), delivering bradycardia pacing, ATP, or shock therapy. Upon detecting VT/VF, the S-ICD requests the LP to deliver ATP, and transitions to a sensitive detection profile (Figure, panels A&E).

Defibrillator 40

Defibrillator Bradycardia Arrhythmia Pacemaker 40

European Journal of Heart Failure

MARCH 19, 2025

During AHF, there is an increased risk of destabilizing the functional substrate and modulatory adding to the risk of ventricular arrhythmias (VAs) already created by the structural substrate. Scientific guidelines provide clear recommendations for the management of arrhythmias in chronic heart failure patients.

Heart Failure 40

Heart Failure Cardiogenic Shock Arrhythmia Heart Rhythm 40

Journal of the American Heart Association

FEBRUARY 13, 2024

BackgroundScreening for atrial fibrillation (AF) may reveal incidental arrhythmias of relevance. We furthermore report treatment decisions because of incidental arrhythmias. We found incidental arrhythmias in 94 patients (11.8%). Journal of the American Heart Association, Ahead of Print. of our cohort patients.

Atrial Fibrillation 40

Atrial Fibrillation Arrhythmia Hospital Tachycardia 40

HeartRhythm

MARCH 31, 2025

Implantable cardioverter-defibrillators (ICDs) are crucial for treating life-threatening ventricular arrhythmias. While effective, these algorithms can occasionally misidentify arrhythmia termination, leading to adverse outcomes.

Defibrillator 40

Defibrillator Arrhythmia Outcomes 40

Journal of Cardiovascular Electrophysiology

DECEMBER 16, 2024

ABSTRACT Aim To evaluate the predictive value of preoperative echocardiographic parameters for occurrence of VAs in patients with preexisting ICD undergoing LVAD implantation. Methods and Results All consecutive patients ( n =264) with previous ICD who underwent LVAD surgery between May 2011 and December 2019 at our institution were included.

Defibrillator 40

Defibrillator Arrhythmia Tricuspid Bicuspid/Mitral 40

HeartRhythm

MARCH 31, 2025

MODULAR ATP, a global clinical trial, assessed a subcutaneous ICD (S-ICD) in wireless communication with a novel leadless pacemaker (LP) to deliver ATP or shock therapy (Tx). The S-ICD requests the LP to deliver ATP at programmable detection rates that are confirmed by the LP.

Defibrillator 40

Defibrillator Pacemaker Arrhythmia 40

HeartRhythm

MARCH 31, 2025

Subcutaneous implantable cardiac monitors (ICM) have the capability to detect cardiac arrhythmia that may lead to pacemaker or defibrillator therapies.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Defibrillator Pacemaker Heart Failure 40

HeartRhythm

APRIL 30, 2024

We conducted this systematic review and meta-analysis to evaluate safety outcomes including risk of ventricular arrhythmias, new onset atrial fibrillation, Implantable Cardiac defibrillators (ICD) shocks, QRS duration reduction, heart failure hospitalizations and mortality.

Heart Failure 40

Heart Failure Arrhythmia Atrial Fibrillation Defibrillator 40

HeartRhythm

MARCH 31, 2025

The use of implantable loop recorders (ILRs) has become common practice to diagnose arrhythmias, potentially leading to the need for pacemakers (PM) or implantable cardioverter defibrillators (ICD).

Pacemaker 40

Pacemaker Defibrillator Arrhythmia 40

HeartRhythm

APRIL 30, 2024

The efficacy of implantable cardioverter-defibrillators (ICD) in patients with a non-ischaemic cardiomyopathy (NICM) is being debated. Deep Learning models enable feature extraction from high-dimensional data, such as cardiac MRI (CMR) and ECG.

Cardiomyopathy 40

Cardiomyopathy Defibrillator Arrhythmia 40

HeartRhythm

MARCH 31, 2025

The most well-known entity in this group is Brugada syndrome (BrS), which is characterized by decreased sodium current (INa), slowed conduction, and lethal arrhythmias. To date, the mainstay treatment remains the implantable cardioverter defibrillator, which is associated with significant adverse events.

Pharmacology 40

Pharmacology Defibrillator Arrhythmia 40

HeartRhythm

MARCH 31, 2025

Patients with a left ventricular assist device (LVAD) with an implantable cardioverter defibrillator (ICD) are more tolerant of sustained ventricular arrhythmias (VA) from the assisted circulation, so shock activation is more likely to occur in the awake state.

Defibrillator 40

Defibrillator Arrhythmia Circulation 40

Circulation

JULY 10, 2024

The rapid technological advancements in cardiac implantable electronic devices such as pacemakers, implantable cardioverter defibrillators, and loop recorders, coupled with a rise in the number of patients with these devices, necessitate an updated clinical framework for periprocedural management.

Defibrillator 49

Defibrillator Pacemaker Technology Nursing 49

HeartRhythm

MARCH 31, 2025

In the first step, patients with at least one non-invasive risk factor (NIRF) were referred for electrophysiology study (second step) and were then considered for implantable cardioverter-defibrillator (ICD) implantation in case of inducible malignant arrhythmia. This report presents the 8-year follow-up findings of the trial.

Myocardial Infarction 40

Myocardial Infarction Preserved Ejection Fraction Defibrillator Electrophysiology 40

HeartRhythm

MARCH 12, 2024

Many patients with mild to moderately reduced left ventricular ejection fraction (LVEF) that require permanent pacemaker (PPM) implantation do not have a concurrent indication for implantable cardioverter-defibrillator (ICD) therapy. However, the risk of ventricular tachycardia/fibrillation (VT/VF) in this population is unknown.

Pacemaker 40

Pacemaker Defibrillator Arrhythmia Tachycardia 40